| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |